MENU
MESO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Mesoblast (MESO) Ownership - Who owns Mesoblast?

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
55 Collins Street
Phone
+61 396396036
Employees
108
Web
https://www.mesoblast.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.08B
P/E Ratio
N/A
Total Cash
47.39M
Projected Growth
N/A
Total Debt
127.33M
Revenue
120.25M
Risk (Beta)
0.91
Dividend Yield
N/A
Total Cash/Share
0.36
Total Debt/Equity
N/A
Revenue/Share
0.93 USD as % of share price
View a ticker or compare two or three
MESO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of biological products

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
55 Collins Street
Phone
+61 396396036
Employees
108
Web
https://www.mesoblast.com
Who owns Mesoblast? MESO symbol Ownership - Tickeron.com